The burgeoning popularity of tirzepatide , initially for diabetes , is creating significant buzz within the British Isles, prompting a notable shift in medication trends. Access these medications remains a complex challenge , with NHS provision currently limited and independent providers offering therapy at a substantial price. Concerns are being r